A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4425 (2006.01) A61P 1/04 (2006.01) A61P 1/16 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) A61P 9/12 (2006.01) A61P 11/00 (2006.01) A61P 15/10 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 31/00 (2006.01) A61P 41/00 (2006.01)
Patent
CA 2547234
The invention relates to the use of quaternary pyridinium salts of for~mula (1), wherein wherein R is NH2, CH3, or N(H)CH2OH group, and X is pharmaceutically acceptable counterion, for the preparation of vasopro~tective agent for the treatment or prevention of conditions or diseases associated with dysfunction of vascular endothelium, oxidative stress, and/or insufficient production of endothelial prostacyclin PGI2, in par~ticular but not exclusively if the above coincides with hypercholes terolemia, hypertriglyceridemia or low HDL level.
L'invention concerne l'utilisation de sels de pyridinium quaternaire de formule (I), dans laquelle R est NH¿2?, CH¿3?, ou un groupe N(H)CH¿2?OH, et X est un contre-ion pharmaceutiquement acceptable, pour la préparation d'un agent vasoprotecteur destiné au traitement ou à la prévention de pathologies ou d'affections associées à un dysfonctionnement de l'endothélium vasculaire, au stress oxydatif, et/ou à la production insuffisante de prostacycline endothéliale PGI¿2?, notamment mais pas exclusivement si les troubles précités coïncident avec une hypercholestérolémie, une hypertriglycéridémie ou un faible taux de lipoprotéines de haute densité.
Chlopicki Stefan
Gebicki Jerzy
Kirby Eades Gale Baker
Pharmena Sa
Pharmena Sp. Z. O.o.
LandOfFree
The use of quaternary pyridinium salts as vasoprotective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of quaternary pyridinium salts as vasoprotective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of quaternary pyridinium salts as vasoprotective agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1689178